Soleus Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-140,000
Closed -$8.79M 102
2026
Q1
$8.79M Sell
140,000
-1,157,094
-89% -$80.6M 0.36% 57
2025
Q4
$86.1M Buy
+1,297,094
New +$83.9M 3.18% 7
2023
Q3
Sell
-33,000
Closed -$4.24M 101
2023
Q2
$4.24M Buy
+33,000
New +$3.99M 0.47% 53
2023
Q1
Sell
-40,000
Closed -$4.53M 82
2022
Q4
$4.53M Buy
40,000
+16,164
+68% +$1.77M 0.65% 42
2022
Q3
$1.92M Sell
23,836
-23,400
-50% -$1.98M 0.26% 57
2022
Q2
$3.52M Buy
47,236
+800
+2% +$73K 0.55% 52
2022
Q1
$5.94M Buy
46,436
+15,400
+50% +$1.68M 0.77% 38
2021
Q4
$4.17M Buy
+31,036
New +$4.46M 0.42% 42
2021
Q3
Sell
-23,536
Closed -$2.51M 74
2021
Q2
$2.51M Sell
23,536
-4,204
-15% -$404K 0.39% 45
2021
Q1
$2.49M Sell
27,740
-4,920
-15% -$462K 0.45% 44
2020
Q4
$3.02M Buy
32,660
+2,328
+8% +$208K 0.4% 27
2020
Q3
$3.13M Sell
30,332
-7,868
-21% -$822K 1.66% 25
2020
Q2
$3.87M Sell
38,200
-15,600
-29% -$1.4M 2.21% 15
2020
Q1
$3.62M Sell
53,800
-16,600
-24% -$1.03M 4.21% 8
2019
Q4
$3.85M Buy
+70,400
New +$3.34M 3.71% 7

Other funds holding DXCM

Soleus Capital Management's DXCM Position: Q2 2026 in Review

Soleus Capital Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 140,000 shares — an estimated $8.79M sold.

Soleus Capital Management first reported a position in DXCM in Q4 2019 and held it in 15 quarters. The position peaked at $86.1M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Soleus Capital Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Soleus Capital Management sold 140,000 DexCom shares in Q2 2026, an estimated $8.79M.
  • Soleus Capital Management first reported a position in DexCom in Q4 2019 and held it in 15 quarters.
  • Soleus Capital Management's DexCom position peaked at $86.1M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.